SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-000043
Filing Date
2021-01-04
Accepted
2021-01-04 08:00:37
Documents
1
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3291
  Complete submission text file 0000899243-21-000043.txt   4825
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 543 LOMBARD ST SAN FRANCISCO CA 94133
Business Address
TOTH ROBERT JOSEPH JR (Reporting) CIK: 0001585020 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 21500221